Standard BioTools Q3 2024 GAAP EPS $(0.07) Beats $(0.09) Estimate, Sales $44.969M Beat $40.998M Estimate

LaBranche & Co -7.61% Post

LaBranche & Co

LAB

1.70

1.70

-7.61%

0.00% Post

Standard BioTools (NASDAQ: LAB) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.09) by 22.22 percent. The company reported quarterly sales of $44.969 million which beat the analyst consensus estimate of $40.998 million by 9.68 percent. This is a 77.27 percent increase over sales of $25.367 million the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via